FEATURED CONTENT

• Recommendations For Optimizing Televisits

  Discover the pros and cons of telehealth visits and what can be done to continuously improve them.

• Call Centers And Clinical Trial

  Gain insight into why the call center must be viewed as an integral component of the clinical trial experience.

• Clinician Reported Outcomes: Let's Make It A Universal Language

  Discover the important role of clinician reported outcomes (ClinROs) when it comes to regulatory submissions.

• Wrestling With The Monster That Is COVID-19

  In this blog, Joan Venticinque tells us about her health journey when she discovered she was positive for COVID-19.

• How To Avoid Selection Bias Through Proactive Action

  Learn how drug makers worldwide need to ensure that conditions for bias are not created as a result of access to devices or WiFi when it comes to clinical research.

• What Can Be Learned From The COVID-19 Vaccine Roll Out?

  The US has already achieved its target of 100 million Americans vaccinated in 100 days. Despite this huge milestone, discover how the registration for the vaccine itself has been anything but simple.

• Decentralized Clinical Trials: You Don’t Have To Do Everything, You Just Have To Start.

  Learn why you don't need to take an all-or-nothing approach when it comes to decentralized trials.

• Decentralized Clinical Trials Represent The Decentralization Of Care: What That Means For Patients

  At the beginning of the pandemic, thousands of clinical trials were suspended for the safety of investigators and participants alike. Once the FDA issued guidance for conducting trials virtually, discover the ways the industry embraced them and their benefits.

• Digital Biomarkers And Endpoints: Why They Matter In A DCT Setting

  Find out how digital biomarkers stand to have a profound impact on, and even enable, the digital transformation of the healthcare industry and DCTs.

• Patient Monitoring Starts With Consent: How To Be A Star At Doing Both Remotely

  Learn how decentralized clinical trials featuring technology-enabled communications are empowering researchers to create a more patient-centric clinical trial and transforming the clinical trial experience for patients.

• Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent

  Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.

• Why eConsent Makes Such A Difference In Patient Adherence And Engagement

  Explore how consent is a critical step that can greatly influence patient enrollment, adherence and retention in the trial.

• Are Sites Onboard With The Shift To Decentralized Clinical Trials (DCTs)?

  As the Senior Director and Co-Owner of Coastal Carolina Research Center, Nathan Morton provides strategic planning and operational oversight for a dedicated research center and clinical staff of 50. In this conversation, learn about his thoughts on the decentralized trial landscape.

• The Language Of eCOAs

  In this article, learn more about COAs, and their electronic counterparts, eCOAs.

• How eCOAs Can Benefit Clinical Trials

  Learn how the built-in flexibility and freedom of eCOAs can enhance many aspects of a clinical trial.

• I Want To Tell You In My Own Words: Patient-Reported Outcomes

  Read on to learn why patient reported outcomes (PROs) are essential, how they can be captured electronically, and how they impact clinical trial participants.

• How To Write Clear And Compelling Patient Recruitment Material To Drive Enrollment And Boost Diversity

  Clinical trials are essential for the development of new medical treatments and devices. However, enrolling patients in clinical trials is one of the most challenging aspects of conducting these studies.

• Let’s Make It A Universal Language: Clinician Reported Outcomes

  Read to learn more about ClinROs, why they are important, the industry governance around them, and how their electronic versions can benefit clinical trials.

• Ready For Remote: eCOA Adapts To A Hybrid World

  Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.

• 5 Reasons Why Patients Might Not Be Interested In Study Participation

  Explore five key reasons patients may opt not to participate in clinical trials and learn how technology can help overcome patients’ concerns.